Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
7
After selected filters
Transcript verified
4
Official transcript summaries on this page
Preliminary briefs
1
Presentation evidence, clearly labelled
Processing
2
Transcript filed or call source found
Tracked companies
0
Watchlist or portfolio matches

Management evidence

Generated 22 Oct, 2:10 am IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
SHOPERSTOP
Shoppers Stop Limited
Consumer · Small
Sep 2026
21 Oct 2026
Transcript verified
Bad
22/100
Optimistic outlook
No comparable prior call
Guidance raised

Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation.

Evidence summary ready
HERITGFOOD
Heritage Foods Limited
FMCG · Micro
Sept 2026
19 Oct 2026
Transcript verified
Bad
0/100
Cautious outlook
Broadly unchanged
No measurable guidance

Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially.

Evidence summary ready
GAJA
Gaja Alternative Asset Management Limited
Financial Services · Micro
Sep 2026
19 Oct 2026
Transcript filed
Result pending
No matching current-quarter result row
Outlook pending
No comparable prior call
Guidance pending

The available source has not produced sufficient structured evidence.

Summary pending
ASTERDM
Aster DM Healthcare Limited
Pharma · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
Broadly unchanged
No measurable guidance

The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis.

Evidence summary ready
HCLTECH
HCL Technologies Limited
IT · Large
Sept 2026
15 Oct 2026
Transcript verified
Good
70/100
Cautious outlook
Broadly unchanged
Guidance maintained

HCLTech delivered solid top‑line growth and margin expansion, driven by strong Advanced AI services and record bookings, while software revenue declined and margin guidance remains cautious.

Evidence summary ready
COCHINSHIP
Cochin Shipyard Limited
Industrials · Mid
Sep 2026
10 Oct 2026
Preliminary brief
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

The company demonstrates strong order book visibility, supported by significant capacity expansion projects recently commissioned and others in the pipeline. Strategic JVs and acquisitions are aimed at diversifying capabilities and market reach, suggesting continued growth momentum.

Evidence summary ready
WABAG
VA Tech Wabag Limited
Infra · Micro
Sept 2026
7 Oct 2026
Transcript filed
Result pending
No matching current-quarter result row
Outlook pending
No comparable prior call
Guidance pending

The available source has not produced sufficient structured evidence.

Summary pending
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.